Abstract
Breast cancer in men is a rare disease whose treatment is derived from the treatment of breast cancer in women. It is caused partly by lack of data, partly by a estimated similarity of the disease in both sexes.
New findings on the clinical and biological characteristics of the male breast cancer should confirm the similarity of female breast cancer or provide evidence that it is a completely different disease requiring individual approach. Deficiencies in treatment strategies can't be caused by the sex of the patient nor the incidence of a rare disease.
These are reasons why a male breast cancer deserves special attention.